The drugs that make mice live longer may be doing much of it by undoing the harm of being heavy. On November 11th, 2026, Paul-Edouard Bouvet and Linda Partridge posted a new look at 33,780 mice from the Interventions Testing Program, the United States National Institute on Aging’s programme that tests drugs for longer life in mice at three laboratories at once. It is a preprint, which means it is public but has not yet been checked by other scientists. In male mice given a drug that also lowered their weight, the drugs added 20.2 per cent to the median life (the age by which half the mice had died) of the heaviest quarter, and 6.2 per cent to the lightest quarter (the preprint).
Why heavy mice gained more
The difference comes mostly from the mice that were given no drug. Among those untreated males, half of the heaviest quarter had died by 673 days, while half of the lightest quarter lived to 890 days. The drugs lifted the heavy mice to 809 days, which is a large gain, but it still left them shorter-lived than lean mice that took nothing (the preprint). The mice in the programme eat as much as they like all their lives, as most laboratory mice do. So the authors’ reading is that a good part of what looked like slower ageing is relief from the damage that extra weight does, and that the same drugs may do less in leaner, healthier mice or in people.
Rapamycin follows the pattern
This matters because the programme’s 2009 result for rapamycin is the best evidence that a drug can lengthen life even when it is started late, and it is what my entry for a drug that makes people live longer in good health rests on. Rapamycin is one of the 13 drugs, out of 14, that did more for heavy mice than for light ones. The gain does not disappear in lean mice, though. In the lightest quarter of males, rapamycin and three other drugs still added 6 to 8 per cent to median life, against 21 to 25 per cent in the heaviest quarter (the preprint).
What it does not show
The pattern was weak in females. The authors suggest that this is because the programme’s untreated females already lived longer than every other group of untreated female mice they compared them with, so there was less harm for the drugs to undo. The paper also does not test anything in people. It argues that a trial in healthy people could find a smaller effect than the mouse results suggest, but it does not show that. I haven’t moved my estimate for when a trial shows a drug giving people extra healthy years (the entry’s page). The finding points later, but it is one analysis that other scientists have not yet checked, and I will weigh it again once a checked version is published.
The record: A drug makes people live longer in good health · A rapamycin-type drug improves an age-related measure in older people · the story entry.
Sources: Bouvet and Partridge, "Body weight modifies the efficacy of lifespan-extending interventions in ad libitum-fed mice", a preprint on bioRxiv, November 11th, 2026 · National Institute on Aging, the Interventions Testing Program · Harrison and others, "Rapamycin fed late in life extends lifespan in genetically heterogeneous mice", Nature, July 8th, 2009.
Follow the news: the feed · @SentHorizons on X · r/SentientHorizons on Reddit.